Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by LithLoveron Aug 22, 2022 6:58pm
136 Views
Post# 34912745

RE:RE:RE:Grail news and everyone is talking about it…..

RE:RE:RE:Grail news and everyone is talking about it…..Read the link again.  It says test results will be released in 2024 and than it says:

  • The test, if successful, could be rolled out to a million people as early as 2024
IF SUCCESSFUL / COULD

It's been posted here over and over again.  The first 2 stages of Grail are under 50% effective and really only show results in Stage 3 or 4.  Grail is not effective in early stage.  

1 million people getting under 50% accurate results in early stage cancers from Grail. OK you keep thinking Stage is faked. 

Grail: 

Stage 1 = 18%
Stage 2 = 43%
Stage 3 = 81%
Stage 4 = 93%


Stagezero has the best results for early detection.  Maybe Grail should be called Stagethree.


frewil11 wrote: Rolled out to a million people in 2024 , thats one thing I always thought was that Stage Zero was so far ahead of the competition regarding time , doesn't seem that far away now does it , and Tripp is playing around with a 177 thousand dollar financing to roll Aristotle out , this company is faked.


<< Previous
Bullboard Posts
Next >>